Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71M Buy
7,475
+93
+1% +$31.8K 0.59% 42
2026
Q1
$2.6M Sell
7,382
-16
-0.2% -$5.7K 0.64% 40
2025
Q4
$2.42M Buy
7,398
+794
+12% +$252K 0.57% 43
2025
Q3
$1.86M Buy
6,604
+177
+3% +$51.3K 0.45% 49
2025
Q2
$1.79M Buy
6,427
+498
+8% +$141K 0.47% 49
2025
Q1
$1.85M Buy
5,929
+328
+6% +$96.9K 0.53% 46
2024
Q4
$1.46M Buy
5,601
+165
+3% +$49K 0.4% 48
2024
Q3
$1.75M Buy
5,436
+76
+1% +$24.9K 0.49% 45
2024
Q2
$1.67M Buy
5,360
+52
+1% +$15.3K 0.51% 44
2024
Q1
$1.51M Buy
5,308
+959
+22% +$281K 0.48% 47
2023
Q4
$1.25M Sell
4,349
-32
-0.7% -$8.72K 0.44% 47
2023
Q3
$1.18M Sell
4,381
-111
-2% -$27.7K 0.46% 46
2023
Q2
$997K Sell
4,492
-259
-5% -$60.1K 0.39% 54
2023
Q1
$1.15M Buy
4,751
+24
+0.5% +$5.89K 0.49% 46
2022
Q4
$1.24M Buy
4,727
+56
+1% +$15K 0.59% 40
2022
Q3
$1.05M Buy
4,671
+164
+4% +$39.8K 0.55% 44
2022
Q2
$1.1M Sell
4,507
-500
-10% -$123K 0.55% 46
2022
Q1
$1.21M Buy
+5,007
New +$1.15M 0.49% 45
2021
Q4
Sell
-4,783
Closed -$1.02M 61
2021
Q3
$1.02M Buy
4,783
+84
+2% +$19.3K 0.44% 49
2021
Q2
$1.15M Sell
4,699
-226
-5% -$55.6K 0.5% 45
2021
Q1
$1.23M Sell
4,925
-93
-2% -$22.2K 0.58% 41
2020
Q4
$1.15M Sell
5,018
-376
-7% -$86.7K 0.57% 44
2020
Q3
$1.37M Buy
5,394
+38
+0.7% +$9.41K 0.77% 35
2020
Q2
$1.26M Sell
5,356
-537
-9% -$123K 0.76% 35
2020
Q1
$1.2M Buy
5,893
+35
+0.6% +$7.64K 0.9% 29
2019
Q4
$1.41M Sell
5,858
-120
-2% -$26.5K 0.85% 32
2019
Q3
$1.16M Buy
5,978
+280
+5% +$53.7K 0.8% 35
2019
Q2
$1.05M Sell
5,698
-233
-4% -$41.7K 0.74% 38
2019
Q1
$1.13M Buy
5,931
+295
+5% +$56.3K 0.85% 33
2018
Q4
$1.1M Buy
5,636
+417
+8% +$81.4K 0.97% 28
2018
Q3
$1.08M Sell
5,219
-2
-0% -$394 0.82% 32
2018
Q2
$964K Sell
5,221
-2,264
-30% -$400K 0.76% 30
2018
Q1
$1.28M Buy
7,485
+665
+10% +$122K 1.04% 22
2017
Q4
$1.19M Buy
+6,820
New +$1.21M 0.98% 22

Other funds holding AMGN

DeDora Capital's AMGN Position: Q2 2026 in Review

DeDora Capital increased its Amgen (AMGN) stake by 1.3% in Q2 2026, buying an estimated $31.8K and bringing the position to 7,475 shares worth $2.71M. The position accounts for 0.59% of the portfolio, ranked #42.

DeDora Capital first reported a position in AMGN in Q4 2017 and has held it in 34 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • DeDora Capital held 7,475 shares of Amgen worth $2.71M as of Q2 2026.
  • DeDora Capital bought 93 Amgen shares in Q2 2026, an estimated $31.8K.
  • Amgen made up 0.59% of DeDora Capital's portfolio in Q2 2026, its #42 holding.
  • DeDora Capital first reported a position in Amgen in Q4 2017 and has held it in 34 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on DeDora Capital's 13F filing for Q2 2026, filed 13 Jul 2026.